News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News AHA 2024 Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots Caitlin E. Cox November 17, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Conference News AHA 2023 ‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE Yael L. Maxwell November 17, 2023
News Conference News AHA 2023 MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia L.A. McKeown November 11, 2023
News Conference News AHA 2022 Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI Shelley Wood November 10, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News AHA 2021 RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor Yael L. Maxwell November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News AHA 2020 OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients Todd Neale November 15, 2020
News Conference News AHA 2020 OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP Shelley Wood November 14, 2020
News Conference News AHA 2020 When PCI Decisions Ignore FFR Results, Patients Pay a Price Caitlin E. Cox November 14, 2020
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2016 Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women L.A. McKeown November 17, 2016
News Conference News AHA 2014 Regional STEMI Care Systems Improve Treatment Times Yael L. Maxwell November 18, 2014